- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
CAPSER REPORT – SAIGON HOSPITAL – ITO
On the morning of April 28, 2021, at the Hospital Hall 140C Nguyen Trong Tuyen, Ward 8, Phu Nhuan, Ho Chi Minh City
CPDP Medbolide Company had a report introducing the product CAPSER (Capsain 0.075%). The report took place with the participation of doctors from SAIGON - ITO hospital.
Company representatives presented recommendations and clinical studies demonstrating the effectiveness of Capsaicin in treating post-shingles pain, diabetic neuropathy, and musculoskeletal pain.
After the report, the doctors had many discussions about the use and safety of the drug.
At the end of the report, the representative of Medbolide Company summarized the main points and sent thanks to the Doctors, hoping to have the opportunity to continue accompanying the Hospital and Patients.
Readers comments